Skip to search formSkip to main contentSkip to account menu

T0156

Known as: T-0156 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

NaphthyridinesPyrimidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Role of new agents affecting NO/cGMP pathway on ovalbumin-sensitized guinea pig trachea
ABSTRACT Asthma is a chronic inflammatory disease in which cell components play important roles. We aimed to evaluate the effects… 
2011
2011
Stimulus-specific blockade of nitric oxide-mediated dilatation by asymmetric dimethylarginine (ADMA) and monomethylarginine (L-NMMA) in rat aorta and carotid artery.
2011
2011
Phosphodiesterase inhibitors block the acceleration of skin permeability barrier repair by red light
Abstract:  We previously demonstrated that exposure to red light (550–670 nm) accelerates epidermal permeability barrier recovery… 
2007
2007
1640: The Phosphodiesterase-5 Inhibitor T0156 Alone and in Combination with Doxazosin Relaxes Porcine Ureter: Implications in Medical Expulsive Therapy for Urolithiasis
2004
2004
T-0156, a novel phosphodiesterase type 5 inhibitor, and sildenafil have different pharmacological effects on penile tumescence and electroretinogram in dogs.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)